Veranstaltungsdetail

Main: Targeted Therapies with New Antiseizure Medications (ASMs) Genetic landscape for rare epileptic syndromes-how does it lead to personalised medicine? Development of preclinical and genetic models in drug discovery of new ASMs, New ASMs in development – new targets and drug repurposing, Real world clinical and pharmacological experience with new ASMs in targeted patient populations, Mind Matters: Exploring Trends in Psychiatry of Epilepsy Impact of psychiatric disorders on long-term prognosis: Why do they matter? Managing depression and anxiety in children with epilepsy, Functional/dissociative seizures: one symptom for many, Psychiatric side effects of ASMs: are new generation drugs better tolerated than previous ones? Cellular Crosstalk in Epilepsy: Let’s just for a moment forget about neurons Astrocytes and Seizure Modulation: Glial Contributions to Network, Microglia in Epilepsy: Immune Activation and Neuroinflammation in Seizure Disorders, Oligodendrocytes and Myelination in Epilepsy: White Matter in Neuronal Circuit Dynamics, The void between cells: ECM contribution to epilepsy, Is it time to abandon open surgery? Minimal invasive open surgical approaches – No time to abandon resective epilepsy surgery, Radiofrequency thermocoagulation – Revival of an underutilized method in the past, Laser interstitial thermal therapy – The dominator among the ablation Methods, Neuromodulation – The opportunity to reversibly modulate epileptic networks, Epilepsy surgery – More a matter of access and education than Methods. Aetiology Matters: Exploring Trends in Paediatric Structural Epilepsies Hypothalamic Hamartomas, Sturge-Weber Syndrome, Focal Cortical Dysplasias and LEATs, Tuberous Sclerosis Complex, MRI-negative but still structural. Current and promising applications of Al in adult epileptology The potential of AI for low-and-middle impact countries, AI to improve the clinical diagnosis of epilepsy, AI-based automatic analysis of scalp and intracerebral EEG, Progress in predicting outcomes using AI, The expected impact of Large Language Models in epilepsy.